ACLARION, INC. Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months
ACLARION, INC. (ACON) had Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months of $236.69 thousand as of 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Rolling Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths · last filed 2026-03-18
- 2025-12-31: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $236.69K.
- 2025-09-30: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $58.22K.
- 2025-06-30: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $114.31K.
- 2025-03-31: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $165.97K.
| Period end | Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months |
|---|---|
| 2025-12-31 | $236.69K 10-K · filed 2026-03-18 |
| 2025-09-30 | $58.22K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $114.31K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $165.97K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $213.27K 10-K · filed 2025-04-09 |
| 2024-09-30 | $52.21K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $96.02K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $133.79K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $169.00K 10-K · filed 2024-03-28 |
| 2023-09-30 | $164.01K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $162.19K 10-Q · filed 2023-08-25 |
| 2023-03-31 | $154.89K 10-Q · filed 2023-07-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |